Published in Bull World Health Organ on January 01, 1960
Yersinia pestis--etiologic agent of plague. Clin Microbiol Rev (1997) 14.63
Intraspecific diversity of Yersinia pestis. Clin Microbiol Rev (2004) 3.03
Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis. Infect Immun (1996) 2.17
Current challenges in the development of vaccines for pneumonic plague. Expert Rev Vaccines (2008) 1.71
Specific identification of fraction I-positive Pasteurella pestis colonies on antiserum-agar plates. Appl Microbiol (1968) 1.61
Genome sequence of the deep-rooted Yersinia pestis strain Angola reveals new insights into the evolution and pangenome of the plague bacterium. J Bacteriol (2010) 1.60
LcrV plague vaccine with altered immunomodulatory properties. Infect Immun (2005) 1.57
Immune defense against pneumonic plague. Immunol Rev (2008) 1.44
Development of in vitro correlate assays of immunity to infection with Yersinia pestis. Clin Vaccine Immunol (2007) 1.37
Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection. Infect Immun (2006) 1.24
Practical applications of new laboratory methods for plague investigations. Bull World Health Organ (1970) 1.21
Immunization with recombinant V10 protects cynomolgus macaques from lethal pneumonic plague. Infect Immun (2008) 1.18
The ABC transporter protein OppA provides protection against experimental Yersinia pestis infection. Infect Immun (2006) 1.14
The Yersinia pestis caf1M1A1 fimbrial capsule operon promotes transmission by flea bite in a mouse model of bubonic plague. Infect Immun (2008) 1.13
Atypical plague bacilli isolated from rodents, fleas, and man. Am J Public Health (1978) 1.09
Pesticinogeny: a characteristic useful for presumptive identification and isolation of Pasteurella pestis. Appl Microbiol (1970) 1.07
Pneumonic plague pathogenesis and immunity in Brown Norway rats. Am J Pathol (2009) 1.04
Yersinia pestis IS1541 transposition provides for escape from plague immunity. Infect Immun (2009) 0.98
Influence of Na(+), dicarboxylic amino acids, and pH in modulating the low-calcium response of Yersinia pestis. Infect Immun (2005) 0.96
The dependence of the Yersinia pestis capsule on pathogenesis is influenced by the mouse background. Infect Immun (2010) 0.95
A monoclonal antibody for the specific diagnosis of plague. Bull World Health Organ (1988) 0.94
A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague. Infect Immun (2008) 0.92
Characterization of an F1 deletion mutant of Yersinia pestis CO92, pathogenic role of F1 antigen in bubonic and pneumonic plague, and evaluation of sensitivity and specificity of F1 antigen capture-based dipsticks. J Clin Microbiol (2011) 0.89
Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice. Vaccine (2010) 0.85
Oral vaccination against bubonic plague using a live avirulent Yersinia pseudotuberculosis strain. Infect Immun (2008) 0.84
LcrV capture enzyme-linked immunosorbent assay for detection of Yersinia pestis from human samples. Clin Diagn Lab Immunol (2005) 0.83
Recent observations on the epidemiology of plague in the United States. Am J Public Health Nations Health (1966) 0.83
Plague in Guinea pigs and its prevention by subunit vaccines. Am J Pathol (2011) 0.82
Fast and simple detection of Yersinia pestis applicable to field investigation of plague foci. PLoS One (2013) 0.82
A Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infection. Microb Pathog (2010) 0.82
Developing live vaccines against plague. J Infect Dev Ctries (2011) 0.81
Identification of encapsulated and non-encapsulated Yersinia pestis by immunofluorescence tests using polyclonal and monoclonal antibodies. Epidemiol Infect (1988) 0.81
Recent findings regarding maintenance of enzootic variants of Yersinia pestis in sylvatic reservoirs and their significance in the evolution of epidemic plague. Vector Borne Zoonotic Dis (2010) 0.80
An IL-12 DNA vaccine co-expressing Yersinia pestis antigens protects against pneumonic plague. Vaccine (2008) 0.80
Evaluation of YadC protein delivered by live attenuated Salmonella as a vaccine against plague. Pathog Dis (2013) 0.80
LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague. Infect Immun (2014) 0.79
A parenteral DNA vaccine protects against pneumonic plague. Vaccine (2010) 0.79
A bivalent typhoid live vector vaccine expressing both chromosome- and plasmid-encoded Yersinia pestis antigens fully protects against murine lethal pulmonary plague infection. Infect Immun (2014) 0.78
Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination. PLoS Negl Trop Dis (2015) 0.78
Novel plasmids and resistance phenotypes in Yersinia pestis: unique plasmid inventory of strain Java 9 mediates high levels of arsenic resistance. PLoS One (2012) 0.76
Multiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plague. Vaccine (2016) 0.75
Rational considerations about development of live attenuated Yersinia pestis vaccines. Curr Pharm Biotechnol (2013) 0.75
Studies on immunization against plague. I. The isolation and characterization of the soluble antigen of Pasteurella pestis. J Immunol (1952) 12.34
The effects of loss of different virulence determinants on the virulence and immunogenicity of strains of Pasteurella pestis. Br J Exp Pathol (1958) 9.78
Staining bacterial smears with fluorescent antibody. I. General methods for Malleomyces pseudomallei. J Bacteriol (1956) 11.23
Staining bacterial smears with fluorescent antibody. III. Antigenic analysis of Salmonella typhosa by means of fluorescent antibody and agglutination reactions. J Bacteriol (1957) 8.39
Staining bacterial smears with fluorescent antibody. IV. Grouping streptococci with fluorescent antibody. J Bacteriol (1958) 8.03
Staining bacterial smears with fluorescent antibody. II. Rapid detection of varying numbers of Malleomyces pseudomallei in contaminated materials and infected animals. J Bacteriol (1956) 7.92
TECHNICAL CONSIDERATIONS IN THE PREPARATION OF FLUORESCENT-ANTIBODY CONJUGATES. Appl Microbiol (1964) 5.86
Staining bacterial smears with fluorescent antibody. VI. Identification of Salmonellae in fecal specimens. J Bacteriol (1959) 3.80
The Streptococcus lactis host-virus system; factors influencing quantitative measurement of the virus. J Bacteriol (1949) 3.65
Field application of fluorescent antibody technique for identification of group A streptococcus. Public Health Rep (1961) 3.54
EPIDEMIOLOGIC CHARACTERIZATION OF GROUP A STREPTOCOCCI BY T-AGGLUTINATION AND M-PRECIPITATION TESTS IN THE PUBLIC HEALTH LABORATORY. Health Lab Sci (1965) 3.51
Specific identification of Bacillus anthracis by means of a variant bacteriophage. J Infect Dis (1955) 2.74
Rapid presumptive identification of entero-pathogenic Escherichia coli in faecal smears by means of fluorescent antibody. 1. Preparation and testing of reagents. Bull World Health Organ (1961) 2.64
IDENTIFICATION OF CORYNEBACTERIUM DIPHTHERIAE WITH FLUORESCENT ANTIBACTERIAL REAGENTS. J Bacteriol (1963) 2.49
The Streptococcus lactis host-virus system; characteristics of virus growth and the effect of electrolytes on virus adsorption. J Bacteriol (1949) 2.42
BACTEREMIA DUE TO GRAM-NEGATIVE RODS. A CLINICAL, BACTERIOLOGIC, SEROLOGIC AND IMMUNOFLUORESCENT STUDY. N Engl J Med (1965) 2.39
Transfer of antigens by phase lysates with particular reference to the l, w antigens of Salmonella. J Bacteriol (1955) 2.39
Rapid identification of Pasteurella pestis with fluorescent antibody. III. Staining Pasteurella pestis in tissue impression smears. J Infect Dis (1959) 2.32
Technical factors affecting the preparation of fluorescent antibody reagents. J Immunol (1961) 2.17
Differential diagnosis of Bacillus cereus, Bacillus anthracis, and Bacillus cereus var. mycoides. J Bacteriol (1958) 2.04
The induction of motility in Bacillus anthracis by means of bacteriophage lysates: significance for the relationship of Bacillus anthracis to Bacillus cereus. J Bacteriol (1955) 1.83
Antibodies against Staphylococcus aureus in nonimmunized rabbits. J Bacteriol (1961) 1.82
Rapid identification of Pasteurella pestis with fluorescent antibody. II. Specific identification of Pasteurella pestis in dried smears. J Infect Dis (1959) 1.78
A simple procedure for the identification of the genus Salmonella by means of a specific bacteriophage. J Lab Clin Med (1954) 1.71
CURRENT STATUS OF IMMUNOFLUORESCENCE TECHNIQUES FOR RAPID DETECTION OF SHIGELLAE IN FECAL SPECIMENS. Appl Microbiol (1965) 1.65
The radioisotope renogram: an external test for individual kidney function and upper urinary tract patency. J Lab Clin Med (1956) 1.55
Studies on tularemia. I. The relation between certain pathogenic and immunogenic properties of variants of Pasteurella tularensis. J Bacteriol (1955) 1.49
A clinical study of a new renal function test: the radioactive diodrast renogram. J Urol (1956) 1.45
NORMALLY OCCURRING STAPHYLOCOCCAL ANTIBODIES IN GERMFREE MICE. J Immunol (1963) 1.37
Replacement of the ureter by small intestine: clinical application and results of the ileal ureter. J Urol (1959) 1.35
Meningitis due to Listeria monocytogenes; report of two cases. J Am Med Assoc (1952) 1.23
Results of the radioisotope renogram and comparison with other kidney tests among hypertensive persons. J Urol (1959) 1.12
Observations on the types and typing of Salmonella paratyphi B cultures in the United States. Am J Public Health Nations Health (1953) 1.11
Cup-patch technique of ileocystoplasty for bladder enlargement or partial substitution. Surg Gynecol Obstet (1959) 1.11
Unilateral renal disease and hypertension: use of the radioactive diodrast renogram as a screening test. J Urol (1957) 1.08
Rapid presumptive identification of enteropathogenic Escherichia coli in faecal smears by means of fluorescent antibody. 2. Use of various types of swabs for collection and preservation of faecal specimens. Bull World Health Organ (1961) 1.07
Industrial air-sampling for anthrax bacteria. AMA Arch Ind Hyg Occup Med (1954) 1.07
Natural occurrence of tularemia in marsupials, carnivores, lagomorphs, and large rodents in southwestern Georgia and northwestern Florida. J Infect Dis (1959) 1.07
A clinical comparison and analysis of radioactive diodarast, hypaque, miokon and urokon renograms as tests of kidney function. J Urol (1958) 1.06
Demonstration of Brucella antibodies in human serum. A comparison of the fluorescent antibody and agglutination techniques. J Immunol (1962) 1.04
Detection of brucellae and their antibodies by fluorescent antibody and agglutination tests. J Bacteriol (1961) 1.02
A CASE OF HUMAN MELIODOSIS: CLINICAL, EPIDEMIOLOGICAL AND LABORATORY FINDINGS. Am J Trop Med Hyg (1964) 1.01
Advances in the radioisotope renogram test. J Urol (1961) 1.01
Rapid identification of Pasteurella pestis with fluorescent antibody. I. Production of specific antiserum with whole cell Pasteurella pestis antigen. J Infect Dis (1959) 0.99
Rectourinary fistula: principles of management and a technique of surgical closure. J Urol (1958) 0.93
Listeriosis: a potential public health problem. Ann N Y Acad Sci (1958) 0.92
The problem of rectal involvement by prostatic cancer. Surg Gynecol Obstet (1957) 0.90
Clinical experience with a new test agent for the radioisotope renogram: sodium orthoiodohippurate-I-131 (hippuran-I-131). J Urol (1961) 0.89
THE PERFORMANCE OF DIVIDED RENAL FUNCTION TESTS IN RENAL HYPERTENSION: A PRACTICAL METHOD. J Urol (1964) 0.88
Sensitivity in vitro of eighteen strains of Pasteurelia tularensis to erythromycin. J Bacteriol (1960) 0.88
Results of ileocystoplasty. J Urol (1958) 0.87
RADIOISOTOPE UROFLOMETRY AND BLADDER RESIDUAL TEST. J Urol (1964) 0.87
Studies on tularemia. II. The antigenic properties of variants of Pasteurella tularensis in various hosts. J Bacteriol (1955) 0.86
Identification of Malleomyces by specific bacteriophages. J Bacteriol (1957) 0.85
The excretory urogram as a kidney function test. J Urol (1960) 0.84
RENOGRAM AND OTHER RADIOISOTOPE TESTS IN THE DIAGNOSIS OF RENAL HYPERTENSION. Am J Surg (1964) 0.83
A new test for vesicoureteral reflux: an external technique using radioisotopes. J Urol (1959) 0.83
Results sigmoidocystoplasty. J Urol (1958) 0.79
Lysis of culture devoid of Vi antigen by Vi I bacteriophage of Salmonella typhosa. Science (1954) 0.79
Technique of sigmoidocystoplasty. Surg Gynecol Obstet (1959) 0.79
Kidney function tests in children. Calif Med (1961) 0.78
Rose bengal and iodopyracet as radiodiagnostic agents in liver and kidney diseases. Ann N Y Acad Sci (1959) 0.78
Diagnosis of "renal" hypertension and prediction of surgical outcome. Application of supplementary renal tests to confirm a positive screening survey. JAMA (1961) 0.78
[CASE OF HUMAN MELIOIDOSIS; CLINICAL, EPIDEMIOLOGICAL AND LABORATORY FINDINGS]. Rev Ecuat Hig Med Trop (1965) 0.76
Further experiences with the radioisotope renogram. Am J Roentgenol Radium Ther Nucl Med (1959) 0.76
The value of chlor-trimeton in the prevention of immediate reactions to 70 per cent urokon. J Urol (1955) 0.76
Cystoplasty to increase bladder capacity. I. Experimental use of isolated patches and loops of large and small bowel to increase urinary bladder capacity in animals. Surg Forum (1957) 0.76
Studies on tularemia. III. The variation of Pasteurella tularensis grown in the presence of normal and immune serum from various hosts. J Bacteriol (1955) 0.75
Prostatic carcinoma involving the rectum; the problem of differentiation from other malignant lesions. Calif Med (1955) 0.75
RADIOISOTOPE RENOGRAPHY--THE FIRST DECADE. Proc R Soc Med (1965) 0.75
A PRACTICAL METHOD OF CONDUCTING CONVENTIONAL, INDIVIDUAL RENAL FUNCTION TESTS AMONG HYPERTENSIVE PATIENTS. Trans Am Assoc Genitourin Surg (1964) 0.75
Prevention of acute allergic and febrile reactions to blood transfusions by prophylactic use of an antihistamine plus an antipyretic. Ann Allergy (1956) 0.75
A new test for vesicoureteral reflux: an external technique using radioisotopes. Trans West Sect Am Urol Assoc (1958) 0.75
CORRECTABLE RENAL HYPERTENSION. X. SURGICAL TREATMENT. Ohio State Med J (1965) 0.75
A CLINICOPATHOLOGICAL CONFERENCE FROM THE OHIO STATE UNIVERSITY HOSPITAL, COLUMBUS, OHIO. Ohio State Med J (1964) 0.75
A CLINICOPATHOLOGICAL CONFERENCE FROM THE OHIO STATE UNIVERSITY HOSPITAL, COLUMBUS, OHIO. Ohio State Med J (1965) 0.75
CORRECTABLE RENAL HYPERTENSION. V. DIAGNOSIS. Ohio State Med J (1964) 0.75
A CLINICOPATHOLOGICAL CONFERENCE FROM THE OHIO STATE UNIVERSITY HOSPITAL, COLUMBUS, OHIO. Ohio State Med J (1964) 0.75
Replacement of the ureter by small intestine: clinical application and results of the ileal ureter. Trans Am Assoc Genitourin Surg (1958) 0.75
CORRECTABLE RENAL HYPERTENSION. II. INCIDENCE AND ETIOLOGIC FACTORS. Ohio State Med J (1964) 0.75
RADIOISOTOPE RENOGRAPHY IN THE DIAGNOSIS OF RENAL VASCULAR HYPERTENSION. Listing Res Cardiovasc Field (1964) 0.75
WHAT IS THE JOB OF THE INDIVIDUAL IN A MASS MEDICAL EMERGENCY. Ohio State Med J (1965) 0.75
CORRECTABLE RENAL HYPERTENSION. XII. PROGNOSIS. Ohio State Med J (1965) 0.75
CORRECTABLE RENAL HYPERTENSION. VI. DIAGNOSIS. Ohio State Med J (1964) 0.75
EXSTROPHY OF THE BLADDER: A RE-EVALUATION OF THE TREATMENT. J Urol (1965) 0.75
CORRECTABLE RENAL HYPERTENSION. IV. DIAGNOSIS 1. Ohio State Med J (1964) 0.75
A CLINICOPATHOLOGICAL CONFERENCE FROM THE CHILDREN 'S HOSPITAL, COLUMBUS, OHIO. Ohio State Med J (1965) 0.75
CORRECTABLE RENAL HYPERTENSION. 8. DIAGNOSIS. Ohio State Med J (1964) 0.75
The value of chlor-trimeton in the prevention of immediate reactions to 70 per cent urokon. Trans West Sect Am Urol Assoc (1955) 0.75
A case of spindle-cell sarcoma of the stomach. Bull Linn Cty Iowa (1947) 0.75
CORRECTABLE RENAL HYPERTENSION. VII. DIAGNOSIS. Ohio State Med J (1964) 0.75
ACLINICOPATHOLOGICAL CONFERENCE FROM THE OHIO STATE UNIVERSITY HOSPITAL, COLUMBUS, OHIO. Ohio State Med J (1964) 0.75
UPRIGHT RENAL ARTERIOGRAPHY AND RENAL HYPERTENSION. Am J Surg (1964) 0.75
CORRECTABLE RENAL HYPERTENSION. SURGICAL TREATMENT. Ohio State Med J (1964) 0.75
CORRECTABLE RENAL HYPERTENSION. XI. SURGICAL TREATMENT. Ohio State Med J (1965) 0.75
The value of chlor-trimeton in the management of acute allergic and febrile reactions to blood transfusion. Ann Allergy (1955) 0.75
TEACHING TRANSURETHRAL SURGERY USING A COW'S UDDER. J Urol (1965) 0.75